Efg Asset Management (North America) Corp. Neurocrine Biosciences Inc Transaction History
Efg Asset Management (North America) Corp.
- $580 Million
- Q1 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 10,149 shares of NBIX stock, worth $1.3 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
10,149
Previous 13,321
23.81%
Holding current value
$1.3 Million
Previous $1.82 Million
38.28%
% of portfolio
0.19%
Previous 0.26%
Shares
13 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.82 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.27 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$709 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$623 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$342 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...